首页 | 本学科首页   官方微博 | 高级检索  
检索        

七味白术散加减治疗脾虚湿困型小儿肠系膜淋巴结炎疗效观察
引用本文:张小林,沈媛,钟宝珠,周璇,陈凤珍,李锦,张东华.七味白术散加减治疗脾虚湿困型小儿肠系膜淋巴结炎疗效观察[J].广州中医药大学学报,2017,34(4).
作者姓名:张小林  沈媛  钟宝珠  周璇  陈凤珍  李锦  张东华
作者单位:1. 广州市白云区中医医院,广东广州,510470;2. 广州市花都区妇幼保健院,广东广州,510800;3. 广州市花都区新华镇医院,广东广州,510800
基金项目:广州市医药卫生科技项目
摘    要:【目的】观察七味白术散加减治疗脾虚湿困型小儿肠系膜淋巴结炎的疗效。【方法】采用多中心随机对照的方法,将150例脾虚湿困型肠系膜淋巴结炎患儿随机分为中药组、西药组和中西医结合组(简称中西医组)各50例。中药组给予口服七味白术散加减治疗,中西医组给予口服七味白术散联合头孢克洛干混悬剂治疗,西药组给予口服头孢克洛干混悬剂治疗。观察3组患儿治疗前及治疗后7 d、1个月及3个月的中医证候变化及腹部肠系膜淋巴结大小变化,比较3组患儿的总有效率及痊愈率,并评价不同治疗方案的安全性。【结果】(1)中药组脱落5例,最终完成观察45例;西药组脱落3例,最终完成观察47例;中西医组脱落7例,最终完成观察43例。(2)中药组和中西医组患儿治疗后7 d、1个月和3个月的总有效率均明显高于西药组(P0.01),治疗后1个月和3个月的痊愈率也均明显高于西药组(P0.01);而中药组与中西医组患儿同时期的总有效率和痊愈率比较,差异均无统计学意义(P0.05)。(3)中药组和中西医组患儿治疗后7 d、1个月和3个月腹部肠系膜淋巴结横径和纵径均明显小于西药组(P0.05);而中药组与中西医组患儿不同时期的腹部肠系膜淋巴结横径和纵径比较,差异均无统计学意义(P0.05)。(4)除脱落病例外,其他患儿均完成全部疗程的治疗;且治疗期间,各组患儿均未出现明显不良反应。【结论】七味白术散加减治疗脾虚湿困型肠系膜淋巴结炎的疗效确切。

关 键 词:七味白术散  脾虚湿困  肠系膜淋巴结炎  儿童

Clinical Effect of Modified Qiwei Baizhu Powder for Mesenteric Lymphadenitis in Children with Spleen Deficiency and Dampness Retention
ZHANG Xiao-Lin,SHEN Yuan,ZHONG Bao-Zhu,ZHOU Xuan,CHEN Feng-Zhen,LI Jin,ZHANG Dong-Hua.Clinical Effect of Modified Qiwei Baizhu Powder for Mesenteric Lymphadenitis in Children with Spleen Deficiency and Dampness Retention[J].Journal of Guangzhou University of Traditional Chinese Medicine,2017,34(4).
Authors:ZHANG Xiao-Lin  SHEN Yuan  ZHONG Bao-Zhu  ZHOU Xuan  CHEN Feng-Zhen  LI Jin  ZHANG Dong-Hua
Abstract:Objective To observe the clinical curative effect of modified Qiwei Baizhu Powder for mesenteric lymphadenitis in children with spleen deficiency and dampness retention. Methods A multi-center randomized and controlled trial was carried out in 150 cases of mesenteric lymphadenitis in children with spleen deficiency and dampness retention. The patients were randomized into Chinese medicine group, western medicine group and combination group, 50 cases in each group. Chinese medicine group was treated with modified Qiwei Baizhu Powder, western medicine group was treated with Cefaclor for Oral Suspension, and the combination group was treated with modified Qiwei Baizhu Powder plus Cefaclor for Oral Suspension. Before treatment and after treatment for 7 days, one month and 3 months, changes in syndrome manifestations and the size of abdominal mesenteric lymph nodes were monitored. The total effective rate and cure rate of the three groups were compared, and the safety of the regimen was also evaluated. Results (1) In Chinese medicine group, 5 patients dropped out, and a total of 45 cases completed the trial; in western medicine group, 3 patients dropped out, and a total of 47 cases completed the trial; in the combination group, 7 patients dropped out, and a total of 43 casescompleted the trial.(2) The total effective rate of Chinese medicine group and combination group after treatment for 7 days, one month and 3 months was significantly higher than that of western medicine group (P < 0.05), and the cure rate after treatment for one month and 3 months was also significantly higher than that of western medicine group (P<0.01). The differences of total effective rate and cure rate were insignificant between Chinese medicine group and combination group(P>0.05) at various time points.(3) After treatment for 7 days, one month and 3 months, the transverse and longitudinal diameters of mesenteric lymph nodes in Chinese medicine group and combination group were shorter than those of western medicine group (P < 0.05) , but the difference was insignificant between Chinese medicine group and combination group (P>0.05). (4) Except for the drop-out cases, all of the children finished the trial. During the treatment, no obvious adverse reaction was found. Conclusion Modified Qiwei Baizhu Powder exerts certain efficacy for the treatment of mesenteric lymphadenitis in children with spleen deficiency and dampness retention.
Keywords:modified Qiwei Baizhu Powder  spleen deficiency and dampness retention  mesenteric lymphadenitis  children
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号